Notes

Complicated characteristics water good quality mixing up within a cozy mono-mictic water tank.
A multidisciplinary approach including gastroenterologists, surgeons, and stoma nurses is essential for IBD patients who will face the challenge of having a stoma during their disease course.
A multidisciplinary approach including gastroenterologists, surgeons, and stoma nurses is essential for IBD patients who will face the challenge of having a stoma during their disease course.
This review addresses the selection of biologic and small molecule therapy for patients with moderate to severe ulcerative colitis (UC). With several new treatment options approved within the past few years, an update in positioning is timely and relevant.

Updates on the safety and comparative efficacy of approved therapeutic agents for UC are presented. Newly approved therapies including tofacitinib and ustekinumab, as well as where to position these treatments are discussed. Data on the first-ever head-to-head trial of biologic therapy in UC are examined. This review provides an evidence-based overview of the optimal management strategies of patients in both the inpatient and outpatient settings.

As we move closer towards the goal of personalized therapy for our patients with UC, we hope to better select appropriate and effective treatment options. Newly approved therapies provide us with additional options for management. learn more Future advancements in predictive serologic, mucosal, genetic, and fecal markers can enable us to tailor therapy to an individual patient.
As we move closer towards the goal of personalized therapy for our patients with UC, we hope to better select appropriate and effective treatment options. Newly approved therapies provide us with additional options for management. Future advancements in predictive serologic, mucosal, genetic, and fecal markers can enable us to tailor therapy to an individual patient.
Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.

Original article, literature search.

Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.

None.

None.

In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.
In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.
To report a case of unilateral chemosis, serous retinal detachment (SRD), and presumed bacillary layer detachment (BLD) in pregnancy.

Clinical examination and multimodal imaging findings were reviewed and analyzed.

A 17-year-old female with severe preeclampsia was found to have unilateral chemosis and bullous SRD. Postpartum optical coherence tomography revealed thickened choroid and presumed BLD. Two weeks later, chemosis and SRD resolved, leaving behind mottled hyperpigmentation, drusen, and subretinal drusenoid deposits.

The combination of chemosis and SRD in preeclampsia is exceedingly rare and it has never previously been reported to occur unilaterally. With delivery, visual acuity, chemosis, choroidal thickness, and SRD all normalize.
The combination of chemosis and SRD in preeclampsia is exceedingly rare and it has never previously been reported to occur unilaterally. With delivery, visual acuity, chemosis, choroidal thickness, and SRD all normalize.
To report the enface optical coherence tomography (OCT) features of intraocular lymphoma.

Retrospective, observational case reportCase description A 59-year-old man, a known case of primary testicular carcinoma complained of right eye blurred vision since 1-week. He had undergone systemic intravenous chemotherapy (R-CHOP regime), orchiectomy and external beam radiotherapy for the primary malignancy previously. His right eye vision was 20/30, 6/6 RS. The right eye anterior segment examination was normal. Fundus examination showed vitreous cells 1+ and a large, bumpy, sub retinal dull-yellow lesion sparing the fovea with multiple discrete yellow retinal lesions at the posterior pole. Magnetic resonance imaging of the brain was normal. Multimodal imaging was used to document the clinical features. On the enface OCT, multiple hyperreflective lesions were identified on the superficial, deep and outer retinal slabs of the scan corresponding to the vertical hyperreflective lesions extending from the retinal nerve fibre layer to the RPE. The sub-RPE lesion can be well-delineated in the choriocapillaris segment. He was treated with multiple injections of intravitreal Methotrexate 400µg/0.1ml along with systemic chemotherapy in conjunction with the oncologist. At 6-months follow-up, fundus lesions had regressed. In addition, resolution of the lesions was noted on the OCT and enface OCT scans.

Enface OCT imaging can be considered for monitoring the therapeutic efficacy following intravitreal chemotherapy in intraocular lymphoma.
Enface OCT imaging can be considered for monitoring the therapeutic efficacy following intravitreal chemotherapy in intraocular lymphoma.
To describe a novel in office procedure which permits the repositioning of an Ozurdex implant from the anterior chamber back into the vitreous cavity.

Description of an office technique for Ozurdex repositioning using a 30-gauge needle.

In both cases the Ozurdex implant was successfully returned to the vitreous cavity. In case 1 the patient's visual acuities one and two weeks after this were 20/70 and 20/40, respectively, and had no further complications. In case 2 the patient returned one week later, with the implant remaining posterior and a visual acuity of 20/40.

The success of this novel technique in these cases demonstrates the potential to avoid a surgical procedure in the event of Ozurdex implant migration to the AC, while at the same time allowing the Ozurdex implant to remain effective in the eye.
The success of this novel technique in these cases demonstrates the potential to avoid a surgical procedure in the event of Ozurdex implant migration to the AC, while at the same time allowing the Ozurdex implant to remain effective in the eye.
Homepage: https://www.selleckchem.com/products/cinchocaine.html